TNSN05074A1 - Piperazines heterocycliques substituees pour le traitement de la schizophrenie - Google Patents

Piperazines heterocycliques substituees pour le traitement de la schizophrenie

Info

Publication number
TNSN05074A1
TNSN05074A1 TNP2005000074A TNSN05074A TNSN05074A1 TN SN05074 A1 TNSN05074 A1 TN SN05074A1 TN P2005000074 A TNP2005000074 A TN P2005000074A TN SN05074 A TNSN05074 A TN SN05074A TN SN05074 A1 TNSN05074 A1 TN SN05074A1
Authority
TN
Tunisia
Prior art keywords
treatment
schizophrenia
substituted heterocyclic
piperazines
heterocyclic piperazines
Prior art date
Application number
TNP2005000074A
Other languages
English (en)
French (fr)
Inventor
Tonja Lynn Andreana
Stephen Sung Yong Cho
James Michael Graham
Tracy Fay Gregory
Jr Harry Ralph Howard
Brian Edward Kornberg
Sham Shridhar Nikam
Derek Andrew Pflum
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2003/003902 external-priority patent/WO2004026864A1/en
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of TNSN05074A1 publication Critical patent/TNSN05074A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TNP2005000074A 2002-09-17 2005-03-17 Piperazines heterocycliques substituees pour le traitement de la schizophrenie TNSN05074A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41147502P 2002-09-17 2002-09-17
PCT/IB2003/003902 WO2004026864A1 (en) 2002-09-17 2003-09-05 Heterocyclic substituted piperazines for the treatment of schizophrenia

Publications (1)

Publication Number Publication Date
TNSN05074A1 true TNSN05074A1 (fr) 2007-05-14

Family

ID=35476681

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2005000074A TNSN05074A1 (fr) 2002-09-17 2005-03-17 Piperazines heterocycliques substituees pour le traitement de la schizophrenie

Country Status (4)

Country Link
CN (1) CN1701072A (es)
CR (1) CR7735A (es)
TN (1) TNSN05074A1 (es)
ZA (1) ZA200502216B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010012121A1 (zh) * 2008-07-28 2010-02-04 江苏国华投资有限公司 芳烷基哌啶（嗪）衍生物及其在治疗精神分裂症中的应用
BRPI0918949A2 (pt) * 2008-09-22 2019-09-24 Hoffmann La Roche moduladores de receptores de 5-ht2a e piperazina d3
CN102718758A (zh) * 2011-03-31 2012-10-10 江苏恒谊药业有限公司 喹啉酮衍生物及其作为抗精神分裂症药物的应用
CN103130737B (zh) * 2011-12-05 2015-12-02 江苏恒谊药业有限公司 环己烷胺类化合物及其作为抗精神分裂症药物的应用
CN113727968B (zh) * 2019-05-14 2024-08-23 杏林制药株式会社 4-氧代吡咯烷-3-甲酰胺衍生物的制备方法
CN112142737B (zh) * 2019-06-29 2022-03-18 武汉珈瑜科技有限公司 一种治疗精神分裂症药物盐酸盐的固体形式

Also Published As

Publication number Publication date
CR7735A (es) 2005-06-15
CN1701072A (zh) 2005-11-23
ZA200502216B (en) 2005-09-26

Similar Documents

Publication Publication Date Title
MA27438A1 (fr) Piperazines heterocycliques substituees pour le traitement de la schizophrenie
MA31373B1 (fr) Composes amino-heterocycliques
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
MA28094A1 (fr) Dérivés [3.1.0] bicycliques servant d'inhibiteurs du transporteur de glycine
MA27568A1 (fr) Derives de pyrrolopyrimidine
TNSN05104A1 (fr) Derives de thiazole pour le traitement de troubles neurodegeneratifs
MA27774A1 (fr) Inhibiteurs de phosphatidylinositol 3-kinase
TNSN04246A1 (fr) Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation
TNSN03130A1 (en) HIV PROTEASE INHIBITORS, COMPOSITIONS CONTAINING THEM, PHARMACEUTICAL USES THEREOF AND MATERIALS FOR THEIR SYNTHESIS
TNSN98154A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant
TNSN99156A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA29429B1 (fr) Composes d'arylamine substitues et leur utilisation comme modulateurs de 5-ht6
TNSN04156A1 (fr) Pyridinones substituees servant de modulateurs de la map-kinase p38
TN2010000175A1 (fr) Piperidino-dihydrothienopyrimidines substituees
MA26875A1 (fr) Composes azapolycycliques a noyau aryle condensé
TNSN98035A1 (fr) Atropisomeres de 3-aryl-4(3h)-quinazolinones, procede pour leur preparation et compositions les contenant
TNSN08445A1 (fr) Derives de triazolopyrazine utiles comme agent anticancereux
TNSN07380A1 (fr) [3.1.0]heteroarylamides bicycliques servant d'inhibiteurs du transport de glycine de type 1
TNSN05073A1 (fr) Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase
MA30696B1 (fr) Derives de l'acide (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetique
MA33053B1 (fr) Inhibiteurs de la poly(adp-ribose) polymerase (parp)
MA27887A1 (fr) Dicetopiperazines substituees et leur utilisation comme antagonistes de l'ocytocine
MA30089B1 (fr) (arylsulfonyl)-pyrasolopiperidines
TNSN05074A1 (fr) Piperazines heterocycliques substituees pour le traitement de la schizophrenie
TNSN99155A1 (fr) 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant